Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2014

Aug 28, 2014

30198_dirs_2014-08-28_adc8fab7-7468-4ce6-ba1b-f486a5719a9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-08-26

Reporting Person: GREGG TERRANCE H (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-26 Common Stock S 5000.0 $46.0533 Disposed 640389 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 395626 Direct
Common Stock 11461 Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $46.03 to $46.10. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: Included in this number are 35,547 unvested restricted stock units granted on March 8, 2012, 5,078 of which shall vest each month through March 8, 2015.

F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.